Ambu CEO: our formula fits well with the hospital market
![Foto: Ambu/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article5941258.ece/ALTERNATES/schema-16_9/Lars%2520Marcher%2520213.jpg)
Danish-based medtech group Ambu presented an interim report showing solid growth Wednesday morning with revenue of DKK 482 million in Q3, organic growth of 9% in local currencies and 21% in Danish kroner – results that please CEO Lars Marcher.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Ambu CEO: We needed a strategic approach to sales
For abonnenter
Ambu CEO: Our profit is under pressure
For abonnenter
Ambu CEO is looking at more than 10 companies
For abonnenter